| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/23/2006 | US7049395 For therapy of inflammatory disorders |
| 05/23/2006 | US7049394 Method for preparing free flow resin |
| 05/23/2006 | US7049336 Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency |
| 05/23/2006 | US7049323 Amidoheterocycles as modulators of the melanocortin-4 receptor |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | US7049305 Bile-acid conjugates providing for sustained systemic concentration of drugs |
| 05/23/2006 | US7049300 C-glycoside compounds for stimulating the synthesis of glycosaminoglycans |
| 05/23/2006 | US7049298 Reacting Arg-Phe together with a reducing sugar to a Maillard reaction under condition sufficient to form the flavor active compound; useful for cosmetics, food and drugs |
| 05/23/2006 | US7049297 Indazole peptidomimetics as thrombin receptor antagonists |
| 05/23/2006 | US7049296 For therapy and prophylaxis of Alzheimer's disease |
| 05/23/2006 | US7049295 Compounds and use thereof to modify transport across cell membranes |
| 05/23/2006 | US7049294 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers |
| 05/23/2006 | US7049293 Peptide and osteogenetic accelerator |
| 05/23/2006 | US7049292 Administering a peptide having a sequence of QPLALEGSLQK in combination with another polypeptide to treat insulin dependent diabetes mellitus (IDDM or Type 1 diabetes) |
| 05/23/2006 | US7049291 For therapy of cartilage, bone, nerve or muscle growth disorder in a mammal |
| 05/23/2006 | US7049290 Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereon |
| 05/23/2006 | US7049289 Labelled glutamine and lysine analogues |
| 05/23/2006 | US7049288 Administering to a host for inhibiting absorption of dietary starch, an effective amount of a phaseolamin and vanadium (vanadium bound by a glycoprotein matrix which is produced by Lactobacillus acidophilus and Saccharomyces cervisiae) |
| 05/23/2006 | US7049287 Nociceptin-based analgesics |
| 05/23/2006 | US7049286 Insulin conjugates and methods of use thereof |
| 05/23/2006 | US7049285 Spacers provide regions of hydrophobicity and positive charge and enhance their interaction with cell membrane to increase the cell trafficking, endosomal disruption, the circulation half-life in blood, and stability |
| 05/23/2006 | US7049284 For therapy of medical conditions resulting from the impaired growth or loss of gastrointestinal tissue, particularly intestinal and pancreatic tissue |
| 05/23/2006 | US7049283 Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| 05/23/2006 | US7049136 Redirection of cellular immunity by receptor chimeras |
| 05/23/2006 | US7049128 For therapy of vascular inflammation and other vascular disorders associated with platelet activation |
| 05/23/2006 | US7049124 Hyaluronidase from the Hirudinaria manillensis isolation, purification and recombinant method of production |
| 05/23/2006 | US7049123 Deoxyribonuclease, gene encoding same and use thereof |
| 05/23/2006 | US7049121 For therapy of cocaine-induced condition; cocaine hydrolysis activity |
| 05/23/2006 | US7049120 Regulation of human mrp5-like protein |
| 05/23/2006 | US7049118 isolated and purified protein and complimentary DNA; culturing a host cell to express the regulatory protein; biodrugs; enzyme inhibitors; anticarcinogenic, antidiabetic agents; nervous system disorders; chronic obstructive pulmonary disorder |
| 05/23/2006 | US7049117 Comprises chimeric polypeptide associated with uracil phosphoribosyl transferase (UPRTase) treating proliferative and infectious diseases; gene therapy; antiproliferative agents; suicide genes |
| 05/23/2006 | US7049096 Polynucleotides encoding a novel human G-protein coupled receptor splice variant HGPRBMY29sv1 |
| 05/23/2006 | US7049089 Respiratory system disorders; cardiovascular disorders; controlling signal transduction |
| 05/23/2006 | US7049081 Antiproliferative gene |
| 05/23/2006 | US7049066 Diagnosis and treatment of myocardial failure |
| 05/23/2006 | US7049063 Lung tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. |
| 05/23/2006 | US7049061 use of R-2,4-diaminobutyric acid as a replacement for gamma-aminobutyric acid to make the hairpin loop; bind to the minor groove of a promoter region of a DNA sequence; tighter binding of the polyamides to the minor groove of DNA and also provides an amine function for derivatizing |
| 05/23/2006 | US7048947 Sustained-release preparation |
| 05/23/2006 | US7048938 somatotropin and a constituent that enhances bioavailability; superior efficacy for inducing weight gain and milk production |
| 05/23/2006 | US7048934 Combined regulation of neural cell production |
| 05/23/2006 | US7048932 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 05/23/2006 | US7048931 polypeptide with prostate-specific proteins, immunogenic portions or a T cell that is specific for cells expressing such a protein |
| 05/23/2006 | US7048930 Expression of core-glycosylated HCV envelope proteins in yeast |
| 05/23/2006 | US7048928 Inhibitor of histamine synthesis, especially of of histidine decarboxylase such as tritoqualine; allergen, e.g., cysteine protease |
| 05/23/2006 | US7048927 treating a cardiovascular disease, especially preventing restenosis in a blood vessel which may occur following a cardiovascular procedure, |
| 05/23/2006 | US7048924 Combination antiviral and interleukin-2 therapy for HIV infection |
| 05/23/2006 | US7048923 Antibodies to mitogenic oxygenases |
| 05/23/2006 | US7048920 A replication-competent adenovirus vector comprising an adenovirus gene essential for replication; use as antitumor agent |
| 05/23/2006 | US7048919 Osteoclast secreted chemokine and uses thereof |
| 05/23/2006 | US7048914 Placental alkaline phosphatase to control diabetes |
| 05/23/2006 | US7048908 Particles for inhalation having sustained release properties |
| 05/23/2006 | US7048906 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 05/23/2006 | CA2322371C Antimicrobial agent against acid resistant and heat-resistant bacteria |
| 05/23/2006 | CA2263921C Oral delayed immediate release formulation and method of preparation therefor |
| 05/23/2006 | CA2259550C Cosmetic or dermatological compound containing at least one natural, recombinant or analogous arachnid silk protein |
| 05/23/2006 | CA2235413C Thermosensitive biodegradable polymers based on poly(ether-ester) block copolymers |
| 05/23/2006 | CA2227792C Polymeric drug formulations |
| 05/23/2006 | CA2173747C Calcium receptor-active arylalkyl amines |
| 05/22/2006 | CA2485178A1 Lactic acid bacteria-derived bacteriocin and uses thereof for prevention or treatment of cancer |
| 05/18/2006 | WO2006053315A2 Methods and compositions for treating cellular proliferative diseases |
| 05/18/2006 | WO2006053162A1 Ptpase inhibitors and t-cell activators for treating cancer |
| 05/18/2006 | WO2006053159A2 Medical device for delivering biologically active material |
| 05/18/2006 | WO2006053130A2 Composition and method for clusterin-mediated stem cell therapy for treatment of atherosclerosis and heart failure |
| 05/18/2006 | WO2006053053A2 Compositions and methods for inhibiting sonic hedgehog activity |
| 05/18/2006 | WO2006053015A2 Composition and method for increasing apoptosis in cancer cells |
| 05/18/2006 | WO2006053014A2 Selective inhibition of rock1 in cardiac therapy |
| 05/18/2006 | WO2006053010A2 Use of antioxidants for gene modulation |
| 05/18/2006 | WO2006052976A2 Improved dosing regimen of temozolomide for treating cancer based on the patient’s mgmt level |
| 05/18/2006 | WO2006052926A2 Tweak as a therapeutic target for treating central nervous system diseases associated with cerebral edema and and cell death |
| 05/18/2006 | WO2006052880A2 Synergistic effects of combined administration of mirtazapine and a stimulant compound |
| 05/18/2006 | WO2006052841A2 Glycolipids |
| 05/18/2006 | WO2006052840A2 Bone tropic peptides |
| 05/18/2006 | WO2006052821A2 Compositions and methods for treatment of protein misfolding and protein aggregation diseases |
| 05/18/2006 | WO2006052795A2 Methods of inhibiting the activity of hsp90 and/or aryl hydrocarbon receptor |
| 05/18/2006 | WO2006052775A2 Peptide anti - tumor agent |
| 05/18/2006 | WO2006052668A2 Induction of antigen specific immunologic tolerance |
| 05/18/2006 | WO2006052637A1 Retrocyclins: antiviral and antimicrobial peptides |
| 05/18/2006 | WO2006052499A1 Capreomycin derivatives and their use as antibacterials |
| 05/18/2006 | WO2006052468A2 Adrenocorticotropic hormone analogs and related methods |
| 05/18/2006 | WO2006052409A2 Peptide and small molecule agonists of epha and their uses |
| 05/18/2006 | WO2006052201A1 Use of derivatives of dipeptides for the manufacture of a medicament for the treatment of microbial infections |
| 05/18/2006 | WO2006052128A1 Treatment of an intestinal adenoma and/or adenocarcinoma by inhibition of notch pathway activation |
| 05/18/2006 | WO2006052031A1 Protein hydrolysate with antidiabetic effect |
| 05/18/2006 | WO2006052013A1 Thienopyrrole compounds and utilization thereof as hcv polymerase inhibitor |
| 05/18/2006 | WO2006052007A1 Glycemic controlling agent |
| 05/18/2006 | WO2006051951A1 REMEDY FOR DIABETES CONTAINING Cdk5 INHIBITOR |
| 05/18/2006 | WO2006051946A1 Novel polypeptide having protease inhibitory activity |
| 05/18/2006 | WO2006051805A1 MUTANT INTERFERON α PROTEINS AND USE THEREOF |
| 05/18/2006 | WO2006051757A1 Remedy or preventive for ischemic cardiac disease or ischemic cardiac myopathy |
| 05/18/2006 | WO2006051545A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 05/18/2006 | WO2006051075A1 Use of survivin to treat kidney failure |
| 05/18/2006 | WO2006051070A1 Method for purifying fsh |
| 05/18/2006 | WO2006050999A2 Methods of reducing body fat |
| 05/18/2006 | WO2006050862A1 Statine derivatives for the treatment of alzheimer's disease |
| 05/18/2006 | WO2006050861A2 Statine derivatives for the treatment of alzheimer's disease |
| 05/18/2006 | WO2006050819A1 Pharmaceutical preparation for the treatment of friedreich’s ataxia |
| 05/18/2006 | WO2006050611A1 Antimicrobial peptides |
| 05/18/2006 | WO2006050571A1 Chlamydia antigens and uses thereof |
| 05/18/2006 | WO2006036406A3 Live microbial microbicides |
| 05/18/2006 | WO2006035311A3 Group a streptococcus crge protein |